Tissue-specific_JJ
regulation_NN
of_IN
the_DT
ecto-5_JJ
'_''
-_NN
nucleotidase_NN
promoter_NN
._.

Role_NN
of_IN
the_DT
camp_NN
response_NN
element_NN
site_NN
in_IN
mediating_VBG
repression_NN
by_IN
the_DT
upstream_JJ
regulatory_JJ
region_NN
._.

We_PRP
have_VBP
isolated_VBN
the_DT
5_CD
'_``
region_NN
of_IN
the_DT
ecto-5_NN
'_''
-_:
nucleotidase_JJ
-LRB-_-LRB-
low_JJ
K_NN
-LRB-_-LRB-
m_NN
-RRB-_-RRB-
5_CD
'_NN
-_:
NT_NN
-RRB-_-RRB-
gene_NN
and_CC
established_VBN
that_IN
a_DT
969_CD
-_:
base_NN
pair_CD
-LRB-_-LRB-
bp_NN
-RRB-_-RRB-
fragment_NN
confers_VBZ
cell-specific_JJ
expression_NN
of_IN
a_DT
CAT_NN
reporter_NN
gene_NN
that_WDT
correlates_VBZ
with_IN
the_DT
expression_NN
of_IN
endogenous_JJ
ecto-5_NN
'_''
-_:
NT_NN
mRNA_NN
and_CC
enzymatic_JJ
activity_NN
._.

A_DT
768-bp_JJ
upstream_JJ
negative_JJ
regulatory_JJ
region_NN
has_VBZ
been_VBN
identified_VBN
that_IN
conferred_VBD
lymphocyte-specific_JJ
negative_JJ
regulation_NN
in_IN
a_DT
heterologous_JJ
system_NN
with_IN
a_DT
244-bp_JJ
deoxycytidine_NN
kinase_NN
core_NN
promoter_NN
._.

DNase_NN
I_NN
footprinting_NN
identified_VBD
several_JJ
protected_JJ
areas_NNS
including_VBG
Sp1_NN
,_,
Sp1\/AP_NN
-2_CD
,_,
and_CC
cAMP_NN
response_NN
element_NN
-LRB-_-LRB-
CRE_NN
-RRB-_-RRB-
binding_NN
sites_NNS
within_IN
the_DT
201-bp_JJ
core_NN
promoter_NN
region_NN
and_CC
Sp1_NN
,_,
NRE-2a_NN
,_,
TCF-1_NN
\/_:
LEF-1_NN
,_,
and_CC
Sp1\/NF-AT_NN
binding_NN
sites_NNS
in_IN
the_DT
upstream_JJ
regulatory_JJ
region_NN
._.

Whereas_IN
the_DT
CRE_NN
site_NN
was_VBD
essential_JJ
in_IN
mediating_VBG
the_DT
negative_JJ
activity_NN
of_IN
the_DT
upstream_JJ
regulatory_JJ
region_NN
in_IN
Jurkat_NN
but_CC
not_RB
in_IN
HeLa_NN
cells_NNS
,_,
mutation_NN
of_IN
the_DT
Sp1\/AP_NN
-2_CD
site_NN
decreased_VBD
promoter_NN
activity_NN
in_IN
both_DT
cell_NN
lines_NNS
._.

Electrophoretic_JJ
mobility_NN
shift_NN
assay_NN
analysis_NN
of_IN
proteins_NNS
binding_VBG
to_TO
the_DT
CRE_NN
site_NN
identified_VBD
both_CC
ATF-1_NN
and_CC
ATF-2_NN
in_IN
Jurkat_NN
cells_NNS
._.

Finally_RB
,_,
phorbol_NN
12-myristate_NN
13-acetate_NN
increased_VBD
the_DT
activity_NN
of_IN
both_CC
the_DT
core_NN
and_CC
the_DT
969-bp_JJ
promoter_NN
fragments_NNS
,_,
and_CC
this_DT
increase_NN
was_VBD
abrogated_VBN
by_IN
mutations_NNS
at_IN
the_DT
CRE_NN
site_NN
._.

In_IN
summary_NN
,_,
we_PRP
have_VBP
identified_VBN
a_DT
tissue-specific_JJ
regulatory_JJ
region_NN
5_CD
'_``
of_IN
the_DT
ecto-5_JJ
'_''
-_:
NT_NN
core_NN
promoter_NN
that_WDT
requires_VBZ
the_DT
presence_NN
of_IN
a_DT
functional_JJ
CRE_NN
site_NN
within_IN
the_DT
basal_JJ
promoter_NN
for_IN
its_PRP$
suppressive_JJ
activity_NN
._.

